OLYMPUS CORPORATION |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 2,174 JPY | -0.57% |
|
-1.63% | +6.57% |
| Apr. 08 | Olympus to Return Land and Building to Shenzhen City Government | MT |
| Mar. 28 | Olympus Corporation Provides Earnings Guidance for the Fiscal Year Ending March 31, 2024 | CI |
Summary
- From a short-term investment perspective, the company presents a deteriorated fundamental situation
- According to Refinitiv, the company's ESG score for its industry is good.
Strengths
- The group's high margin levels account for strong profits.
- The company is in a robust financial situation considering its net cash and margin position.
Weaknesses
- The potential for earnings per share (EPS) growth in the coming years appears limited according to current analyst estimates.
- The company appears highly valued given the size of its balance sheet.
- The firm pays small or no dividend to shareholders. For that reason, it is not a yield company.
- For the past year, analysts have significantly revised downwards their profit estimates.
- For the last few months, analysts have been revising downwards their earnings forecast.
- Over the past twelve months, analysts' opinions have been revised negatively.
Ratings chart - Surperformance
Chart ESG Refinitiv
Sector: Advanced Medical Equipment & Technology
| 1st Jan change | Capi. | Investor Rating | ESG Refinitiv | |
|---|---|---|---|---|
| +6.57% | 16.39B | A- | ||
| +7.69% | 218B | B | ||
| +6.11% | 182B | B- | ||
| +11.14% | 132B | B- | ||
| +26.85% | 108B | A- | ||
| +14.60% | 52.98B | B+ | ||
| -1.89% | 47.59B | B+ | ||
| -1.68% | 39.96B | A | ||
| +10.94% | 39.22B | - | ||
| +19.76% | 26.94B | B+ |
Investor Rating
Trading Rating
ESG Refinitiv
Financials
Sales growth
Earnings Growth
EBITDA / Sales
Profitability
Finances
Valuation
P/E ratio
EV / Sales
Price to Book
Price to Free Cash Flow
Yield
Momentum
1 year Revenue revision
4 months Revenue revision
7 days Revenue revision
1 year EPS revision
4 months EPS revision
Consensus
Analyst Opinion
Potential Price Target
4m Target Price Revision
4m Revision of opinion
12m Revision of opinion
Business Predictability
Analyst Coverage
Divergence of Estimates
Divergence of analysts' opinions
Divergence of Target Price
Earnings quality
Environment
Emissions
Innovation
Use of resources
Governance
CSR Strategy
Management
Shareholders
Controversy
Controversy
Technical analysis
ST Timing
MT Timing
LT Timing
RSI
Bollinger Spread
Unusual volumes
- Stock Market
- Equities
- 7733 Stock
- Ratings Olympus Corporation
